2020
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials
Bikdeli B, Chatterjee S, Kirtane AJ, Parikh SA, Andreozzi GM, Desai NR, Francese DP, Gibson CM, Piazza G, Goldhaber SZ, Eikelboom JW, Krumholz HM, Stone GW. Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials. Seminars In Thrombosis And Hemostasis 2020, 46: 908-918. PMID: 33086402, DOI: 10.1055/s-0040-1716874.Peer-Reviewed Original ResearchConceptsDeep vein thrombosisUse of sulodexideCause mortalityCardiovascular mortalityReduced oddsPulmonary embolismOdds ratioOdds of VTESafety of sulodexideCardiovascular risk factorsCochrane Central RegisterPeripheral arterial diseaseHistory of MIThrombotic cardiovascular diseasesRandom-effects modelCardiovascular efficacyOral glycosaminoglycansCardiovascular outcomesHemorrhagic eventsCentral RegisterVein thrombosisControlled TrialsArterial diseaseRandomized trialsRisk factors
2001
Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons
Abramson JL, Williams SA, Krumholz HM, Vaccarino V. Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons. JAMA 2001, 285: 1971-1977. PMID: 11308433, DOI: 10.1001/jama.285.15.1971.Peer-Reviewed Original ResearchConceptsModerate alcohol consumptionHeart failureHeart failure ratesMyocardial infarctionAlcohol consumptionOlder personsNonfatal heart failure eventsHistory of MIHeart failure eventsProspective cohort studyHeart failure riskBody mass indexPopulation-based sampleCohort studyCurrent smokingMass indexMI riskPulse pressureFailure rateRelative riskAmount of alcoholMAIN OUTCOMELower riskElderly personsBaseline